Open
Actively Recruiting
Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients
About
Brief Summary
A multicenter, randomized, adaptive allocation clinical trial to determine if increasing durations of induced hypothermia are associated with an increasing rate of good neurological outcomes and to identify the optimal duration of induced hypothermia for neuroprotection in comatose survivors of cardiac arrest.
Primary Purpose
Study Type
Phase
Eligibility
Gender
Healthy Volunteers
Minimum Age
Maximum Age
Inclusion Criteria:
- Coma after resuscitation from out of hospital cardiac arrest
- Cooled to <34 deg C with 240 minutes of cardiac arrest
- Definitive temperature control applied
- Age ≥ 18 years
- Informed consent from legal authorized representative (LAR) including intent to maintain life support for 96 hours
- Enrollment within 6 hours of initiation of cooling
Exclusion Criteria:
- Hemodynamic instability
- Pre-existing neurological disability or condition that confounds outcome determination
- Pre-existing terminal illness, unlikely to survive to outcome determination
- Planned early withdrawal of life support
- Presumed sepsis as etiology of arrest
- Prisoner
Join this Trial
Contact our clinical trial navigators for opportunities that may be suitable for you
Study Stats
Protocol No.
20-001122
Category
Heart/Cardiovascular Diseases
Principal Investigator
Contact
Location
- UCLA Westwood